This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zabaleta-Lanz, M Articles by Bianco, N E Search for Related Content PubMed PubMed Citation Articles by Zabaleta-Lanz, M Articles by Bianco, N E Social Bookmarking                   What's this?

Silent nephritis in systemic lupus erythematosus

Institute of Immunology, Venezuelan Central University, Caracas, Venezuela, inmuno{at}cantv.net

R E Vargas-Arenas

Vargas Hospital Department of Medicine, Venezuelan Central University, Caracas, Venezuela

F Tápanes

Institute of Immunology, Venezuelan Central University, Caracas, Venezuela

I Daboin

Institute of Pathology, Faculty of Medicine, Venezuelan Central University, Caracas, Venezuela

J Atahualpa Pinto

Institute of Pathology, Faculty of Medicine, Venezuelan Central University, Caracas, Venezuela

N E Bianco

Institute of Immunology, Venezuelan Central University, Caracas, Venezuela

Silent lupus nephritis (SLN) was investigated in 42 renal asymptomatic patients and compared with 49 untreated patients with overt lupus nephropathy (OLN). Urinary sediment, quantitative proteinuria, creatinine clearance, antinuclear antibodies (ANA), complement, circulating immune complexes (CIC) and renal biopsies were evaluated in all of the patients. Forty-one out of the 42 (97.6%) patients had SLN according to histopathological findings. Results showed that the mean age, female=male ratio and the clinical activity index (SLEDAI) were similar in both groups (P > 0.05). The prevalence of ANA, anti-ds DNA, anti-ENA autoantibodies and C4 serum levels showed no statistical differencesbetween the two groups (P > 0.05). Conversely, in the OLN group, elevated CIC and diminished CH₅₀ and C3 serum levels were significantly different (P < 0.01). WHO class II was the predominant renal lesion in the group with SLN (P < 0.0001), whereas class IV was in the OLN patients (P < 0.0001).

We conclude that, in our series, SLN was highly prevalent in renal asymptomatic patients with otherwise systemic lupus erythematosus. Furthermore, abnormal levels of CIC, CH₅₀ and C3 associated with WHO class II suggest a moderate but ongoing activation of immune-mediated renal injury mechanisms.

Key Words: lupus nephritis • overt lupus nephropathy • systemic lupus erythematosus • silent lupus nephritis

Lupus, Vol. 12, No. 1, 26-30 (2003)
DOI: 10.1191/0961203303lu259oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				O Traitanon, Y Avihingsanon, V Kittikovit, N Townamchai, T Kanjanabuch, K Praditpornsilpa, J Wongchinasri, K Tungsanga, and S Eiam-Ong Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study Lupus, August 1, 2008; 17(8): 744 - 751. [Abstract] [PDF]

				M E Zabaleta-Lanz, L E Munoz, F J Tapanes, R E Vargas-Arenas, I Daboin, Y Barrios, J A Pinto, and N E Bianco Further description of early clinically silent lupus nephritis Lupus, December 1, 2006; 15(12): 845 - 851. [Abstract] [PDF]